Fol. Biol. 2011, 57, 145-150
https://doi.org/10.14712/fb2011057040145
The Influence of Vascular Endothelial Growth Factor (VEGF) Polymorphism on the Progression of Chronic Glomerulonephritides
References
1. 2009) Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. Kidney Int. 75, 1340-1348.
< , Y., Benjachat, T., Tassanarong, A., Sodsai, P., Kittikovit, V., Hirankarn, N. (https://doi.org/10.1038/ki.2009.75>
2. 2007) Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp. Nephrol. 107, 30-40.
< , M. R., Czech, K. A., Arend, L. J., Witte, D. P., Devarajan, P., Potter, S. S. (https://doi.org/10.1159/000106775>
3. 2001) Circulating VEGF and TGF-β1 in children with idiopathic nephrotic syndrome. J. Nephrol. 14, 263-269.
, H. I., Lee, J. H., Hahn, H., Park, H. W., Ha, I. S., Choi, Y. (
4. 2010) Interleukin-18, transforming growth factor-β, and vascular endothelial growth factor gene polymorphisms and susceptibility to primary glomerulonephritis. Tissue Antigens 76, 289-296.
< , H. J., Cho, J. H., Kim, J. C., Seo, H. J., Hyun, S. H., Kim, G. H., Choi, J. Y., Ryu, H. M., Cho, J. H., Park, S. H., Kim, Y. L., Han, S., Kim, C. D. (https://doi.org/10.1111/j.1399-0039.2010.01515.x>
5. 2006) Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy. Ren. Fail. 28, 15-20.
< , K. M., Szeto, C. C., Lai, F. M., Poon, P., Wong, T. Y., Li, P. K. (https://doi.org/10.1080/08860220500461203>
6. 2007) Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int. 72, 337-347.
< , L. C., Liu, G., Perez-Torres, I., Kanswar, Y. S., AvilaCasado, C., Chugh, S. S. (https://doi.org/10.1038/sj.ki.5002302>
7. 2005) Biomarkers of endothelial injury in focal segmental glomerulosclerotic nephrosis. Ren. Fail. 27, 393-395.
< , N., Butthep, P., Futrakul, P. (https://doi.org/10.1081/JDI-65301>
8. 2006) Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis. Virchows Arch. 450, 81-92.
< , C. S., Câmpean, V., Kuhlmann, A., Dimmler, A., Reulbach, U., Forster, C., Aigner, T., Acker, T., Plate, K., Amann, K. (https://doi.org/10.1007/s00428-006-0340-0>
9. 2009) Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am. J. Pathol. 175, 1883-1895.
< , S., Moeller, M. J., Theilig, F., Kaissling, B., Sijmonsma, T. P., Jugold, M., Akeson, A. L., TraykovaBrauch, M., Hosser, H., Hähnel, B., Gröne, H. J., Koesters, R., Kriz, W. (https://doi.org/10.2353/ajpath.2009.080792>
10. 2000) Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int. 57, 2343-2349.
< , E. O., Teppo, A. M., Grönhagen-Riska C. (https://doi.org/10.1046/j.1523-1755.2000.00094.x>
11. Johnson, R. J., Floege, J., Rennke. H. G. (2007) Introduction to glomerular disease: pathogenesis and classification. In: Comprehensive Clinical Nephrology, eds. Feehaly, J., Floege, J., Johnson, R. J., pp. 181-192, Mosby Inc., Maryland Heights, MO.
12. 2002) VEGF is an essential molecule for glomerular structuring. Nephrol. Dial. Transplant. 17, 25-27.
< , Y., Tokunaga, H., Miyamoto, K. Tomita, K. (https://doi.org/10.1093/ndt/17.suppl_9.25>
13. 2006) Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145, 247-254.
< , A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. L., Hendriksen, S., Kusek, J. W., Van Lente, F. (https://doi.org/10.7326/0003-4819-145-4-200608150-00004>
14. 2007) Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J. Am. Soc. Nephrol. 18, 2094-2104.
< , E., Morimoto, M., Kitajima, S., Koike, T., Yu, Y., Shiiki, H., Nagata, M., Watanabe, T., Fan, J. (https://doi.org/10.1681/ASN.2006010075>
15. 2010) Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis. Lab. Invest. 90, 1468-1481.
< , Y., Shimizu, A., Kataoka, M., Arai, T., Ishikawa, A., Du, X., Saito, S. K., Aki, K., Nagasaka, S., Mii, A., Fujita, E., Fukuda, Y. (https://doi.org/10.1038/labinvest.2010.130>
16. 2010) Novel insights into the glomerular structure. Dtsch. Med. Wochenschr. 135, 1232-1236.
< , M. J. (https://doi.org/10.1055/s-0030-1255142>
17. 2007) The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis. Ren. Fail. 29, 779-784.
< , S., Balal, M., Tanriverdi, K., Sertdemir, Y., Baslamisli, F. (https://doi.org/10.1080/08860220701540136>
18. 2008) Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. Kidney Blood Press. Res. 31, 398-403.
< , J., Obeidová, H., Leníček, M., Štekrová, J., Merta, M., Maixnerová, D., Vítek, L., Viklický, O., Tesař, V. (https://doi.org/10.1159/000180269>
19. 2002) Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 13, 260-264.
< , M., Fryer, A. A., Pravica, V., Brogan, I. J., Ramsay, H. M., Hutchinson, I. V., Harden, P. N. (https://doi.org/10.1681/ASN.V131260>
20. 2005) VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol. Dial. Transplant. 20, 2427-2432.
< , A. M., Coupes, B. M., Brennan, M. F., Ralph, S. A., Short, C. D., Brenchley, P. E. C. (https://doi.org/10.1093/ndt/gfi029>